The National Marrow Donor Program® (NMDP)/Be The Match® and Be The Match BioTherapies® Mark Clinical Trials Day With New Resources and Services for Patients, Researchers, and Industry Sponsors
17 mai 2023 08h12 HE
|
Be The Match
MINNEAPOLIS, May 17, 2023 (GLOBE NEWSWIRE) -- The National Marrow Donor Program® (NMDP)/Be The Match® and Be The Match BioTherapies® launched a new web resource page and free white paper, “Paving...
Inotiv, Inc. Announces Second Quarter Fiscal 2023 Financial Results
11 mai 2023 16h05 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 11, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Expands Safety Pharmacology Offering to Include Cardiopulmonary Telemetry
04 mai 2023 08h33 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 04, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development...
Inotiv, Inc. to Report Fiscal 2023 Second Quarter Financial Results and Host Conference Call on Thursday, May 11, 2023
26 avr. 2023 08h33 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., April 26, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical...
Inotiv, Inc. Announces First Quarter Fiscal 2023 Financial Results
13 févr. 2023 16h05 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. to Report Fiscal 2023 First Quarter Financial Results and Host Conference Call on Monday, February 13, 2023
06 févr. 2023 22h45 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv Selected as a Winner of the 2023 Top Workplaces USA Award
01 févr. 2023 13h15 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Changes to Board of Directors
23 janv. 2023 16h40 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2022 Financial Results
10 janv. 2023 16h05 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results and Host Conference Call on Tuesday, January 10, 2023
04 janv. 2023 16h30 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...